Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Antibiotice S.A., commonly referred to as Antibiotice, is a leading pharmaceutical preparation manufacturer headquartered in Iași, Romania. Established in 1955, the company has a long-standing history of producing high-quality medicines and pharmaceutical products, serving both domestic and international markets.
Specialising in the development and manufacturing of antibiotics, injectables, and other pharmaceutical formulations, Antibiotice is recognised for its commitment to quality and innovation. Its core products are distinguished by their adherence to strict regulatory standards, making the company a notable player within the pharmaceutical industry in Eastern Europe. With a strong market presence and a focus on research and development, Antibiotice continues to uphold its reputation as a trusted provider of essential medicines.
58
DitchCarbon score
+16 vs industry average
Antibiotice’s score of 58 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Antibiotice?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Antibiotice's reported carbon emissions
Antibiotice, a Pharmaceutical Preparation Manufacturing company headquartered in Romania, reported its 2025 Scope 1 emissions as 10,115.65 kg CO2e, Scope 2 emissions (market-based) as 1,765,000 kg CO2e, and Scope 3 emissions as 33,949.51 kg CO2e.
Looking back, in 2024, the company's Scope 1 emissions were 9,495.41 kg CO2e, Scope 2 emissions (market-based) were 1,296.33 kg CO2e, and Scope 3 emissions were 41,642.26 kg CO2e. For 2023, Antibiotice's Scope 1 emissions were 9,493.39 kg CO2e and Scope 2 emissions (location-based) were 5,370.1 kg CO2e. In 2022, Scope 1 emissions were 9,937.24 kg CO2e and Scope 2 emissions (location-based) were 5,259.21 kg CO2e.
Antibiotice has committed to significant climate action. The company aims to reduce its Scope 1 and Scope 2 emissions by 46% by 2030, using 2019 as a baseline year. Additionally, Antibiotice targets a 10% reduction in carbon emissions for upstream transport and distribution operations (Scope 3) by 2030, with 2023 as the base year. Antibiotice is recognised by the Science Based Targets initiative (SBTi) as having committed to near-term targets.
Assessing Antibiotice as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Antibiotice and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Antibiotice’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
1 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
See details
Active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Antibiotice3 months ago
58
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Antibiotice’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more